A prospective trial comparing a silicone elastomer intravenous cannula (Visis) with a polytetrafluoroethylene cannula (Cathlon).
Post-infusion phlebitis remains one of the most frequent causes of hospital morbidity with an incidence varying between 13 and 39 per cent (1-4). A recent study indicated that a silicone elastomer cannula (Visis) had desirable properties (5). We have carried out a prospective trial comparing the value of such a cannula with a Teflon cannula (Cathlon) already in routine use.